Abstract
The health burden associated with hypertension in the world is very large. Current estimates suggest that there are over 1 billion individuals with hypertension worldwide with the World Health Organisation estimating that this will increase to 1.5 billion by 2025. Between 35% and 45% of individuals over 25 years demonstrate hypertension with prevalence varying with geographical location and socioeconomic status. In humans, a continuous and incremental risk exists between blood pressure (BP) and cardiovascular disease, stroke and kidney disease. The significant health and economic impact of hypertension has, therefore, driven the requirement for a better understanding of factors, including genetic factors, that may contribute to the development of hypertension. An understanding of these genetic associations might not only improve individual and population risk prediction but, more importantly, may identify novel pathophysiological pathways that are involved in BP regulation and which may also act as pathway targets for new anti-hypertensive drug development assisting with personalisation of anti-hypertensive therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
- 3.
1000 Genome project; http://www.internationalgenome.org/about/
- 4.
- 5.
99 Lives Cat Genome Sequencing Initiative: http://felinegenetics.missouri.edu/99lives
References
Arora P, Wu C, May Khan A, Bloch DB, Davis-Dusenbery BN, Ghorbani A et al (2013) Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest 123(8):3378–3382
Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A et al (2015) A global reference for human genetic variation. Nature 526(7571):68–74
Azizan EAB, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45(9):1055–1060
Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA et al (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402(6764):880–883
Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45(4):440–444
Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Maillard M et al (2005) High heritability of ambulatory blood pressure in families of East African descent. Hypertension 45(3):445–450
Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR et al (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482(7383):98–102
Boyko AR (2011) The domestic dog: man’s best friend in the genomic era. Genome Biol 12(2):216
Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661–678
Calsyn JDR, Green RA (2010) Contralateral adrenocortical adenoma in a cat. J Am Anim Hosp Assoc 46(1):36–42
Cerame B, New M (2000) Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess. J Pediatr Endocrinol Metab 13(9):1537–1547
Devuyst O, Pattaro C (2017) The UMOD locus: insights into the pathogenesis and prognosis of kidney disease. J Am Soc Nephrol 29(3):713–726
Dobrian AD, Schriver SD, Lynch T, Prewitt RL (2003) Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am J Physiol Ren Physiol 285(4):F619–F628
Ehret GB, Caulfield MJ (2013) Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J 34(13):951–961
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI et al (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478(7367):103–109
Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T et al (2016) The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet 48(10):1171–1184
Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ (2001) Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 42(3):122–129
Fernandes-Rosa FL, Giscos-Douriez I, Amar L, Gomez-Sanchez CE, Meatchi T, Boulkroun S et al (2015) Different somatic mutations in multinodular adrenals with aldosterone-producing adenoma. Hypertension 66(5):1014–1022
Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A (2000) Familial aggregation of blood pressure: a population-based family study in eastern Finland. J Hum Hypertens 14(7):441–445
Gandolfi B, Alhaddad H (2015) Investigation of inherited diseases in cats: genetic and genomic strategies over three decades. J Feline Med Surg 17(5):405–415
Gandolfi B, Gruffydd-Jones TJ, Malik R, Cortes A, Jones BR, Helps CR et al (2012) First WNK4-Hypokalemia Animal Model Identified by Genome-Wide Association in Burmese Cats. PLoS One 7(12):e53173
Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN et al (2013) Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet 22(8):1663–1678
Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A et al (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289(5476):119–123
Gilson SD, Withrow SJ, Wheeler SL, Twedt DC (1994) Pheochromocytoma in 50 dogs. J Vet Intern Med 8(3):228–232
Goldblatt BYH, Lynch J, Ramon F, Ph D, Summerville WW (1934) Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischaemia. J Exp Med 59(3):347–379
Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS et al (2014) Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 63(3):551–558
Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM et al (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41(3):342–347
Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y et al (1995) Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11(1):76–82
Havlik RJ, Garrison RJ, Feinleib M, Kannel WB, Castelli WP, Mcnamara PM (1979) Blood pressure aggregation in families. Am J Epidemiol 110(3):304–312
Holden LA, Arumilli M, Hytönen MK, Hundi S, Salojärvi J, Brown KH et al (2018) Assembly and analysis of unmapped genome sequence reads reveal novel sequence and variation in dogs. Sci Rep 8(1):1–11
Holt DE, Henthorn P, Howell VM, Robinson BG, Benn DE (2014) Succinate dehydrogenase subunit D and succinate dehydrogenase subunit B mutation analysis in canine phaeochromocytoma and paraganglioma. J Comp Pathol 151(1):25–34
Hottenga J-J, Boomsma DI, Kupper N, Posthuma D, Snieder H, Willemsen G et al (2005) Heritability and stability of resting blood pressure. Twin Res Hum Genet 8(5):499–508
Huhtinen M, Derré G, Renoldi HJ, Rinkinen M, Adler K, Aspegrén J et al (2015) Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats. J Vet Intern Med 29(3):786–793
Iacobone M, Schiavi F, Bottussi M, Taschin E, Bobisse S, Fassina A et al (2011) Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas? Surgery 150(6):1194–1201
Imai G, Satoh T, Kumai T, Murao M, Tsuchida H, Shima Y et al (2003) Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1. Hypertens Res 26(4):339–347
Javadi S, Djajadiningrat-Laanen SC, Kooistra HS, Van Dongen AM, Voorhout G, Van Sluijs FJ et al (2005) Primary hyperaldosteronism, a mediator of progressive renal disease in cats. Domest Anim Endocrinol 28(1):85–104
Jensen J, Henik R, Brownfield M, Armstrong J (1997) Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Am J Vet Res 58(5):535–540
Jepson RE, Syme HM, Elliott J (2014) Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate. J Vet Intern Med 28(1):144–153
Jepson RE, Warren HR, Syme HM, Elliott J, Munroe PB (2016) Uromodulin gene variants and their association with renal function and blood pressure in cats: a pilot study. J Small Anim Pract 57(11):580–588
Ji W, Foo JN, O’Roak BJ, Zhao H, Larson MG, Simon DB et al (2008) Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40(5):592–599
Johnson T, Gaunt TR, Newhouse SJ, Padmanabhan S, Tomaszewski M, Kumari M et al (2011) Blood pressure loci identified with a gene-centric array. Am J Hum Genet 89(6):688–700
Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X et al (2011) Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 43(6):531–538
Keele SJ, Smith KC, Elliott J, Syme HM (2009) Adrenocortical morphology in cats with chronic kidney disease (CKD) and systemic hypertension. J Vet Intern Med 23(6):1328
Kellis M, Wold B, Snyder MP, Bernstein BE, Kundaje A, Marinov GK et al (2014) Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A 111(17):6131–6138
Kimura S, Mulfins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F et al (1992) High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 1(3):821–827
Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES et al (1995) Male–female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146
Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, De Geus EJC (2005) Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 45(1):80–85
Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P et al (2000) A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37(11):831–835
Langley SR, Bottolo L, Kunes J, Zicha J, Zidek V, Hubner N et al (2013) Systems-level approaches reveal conservation of trans-regulated genes in the rat and genetic determinants of blood pressure in humans. Cardiovasc Res 97(4):653–665
Lerman LO, Chade AR, Sica V, Napoli C (2005) Animal models of hypertension: an overview. J Lab Clin Med 146(3):160–173
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A et al (2009) Genome-wide association study of blood pressure and hypertension. Nat Genet 41(6):677–687
Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S et al (1992) A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262
Lifton R, Gharavi A, Geller D (2001) Molecular mechanisms of human hypertension. Cell 104:545–556
Liu C, Li H, Qi Q, Lu L, Gan W, Loos RJF et al (2011) Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans. J Hypertens 29(1):70–75
Liu C, Kraja AT, Smith JA, Brody JA, Franceschini N, Bis JC et al (2016) Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat Genet 48(10):1162–1170
Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O et al (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44(4):456–460
Luft FC, Volhard F, Helios C, Delbrück M, Medicine M (2003) Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res 1(4):291–300
Maass PG, Aydin A, Luft FC, Schächterle C, Weise A, Stricker S et al (2015) PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet 47(6):647–653
Mai W, Seiler GS, Lindl-bylicki BJ, Zwingenberger AL (2015) CT and MRI features of carotid body paragangliomas in 16 dogs. Vet Radiol Ultrasound 56(4):374–383
Mellersh CS, Ostrander EA (1997) The canine genome. Adv Vet Med 40:191–216
Montague MJ, Li G, Gandolfi B, Khan R, Aken BL, Searle SMJ et al (2014) Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication. Proc Natl Acad Sci U S A 111(48):17230–17235
Mullikin JC, Hansen NF, Shen L, Ebling H, Donahue WF, Tao W et al (2010) Light whole genome sequence for SNP discovery across domestic cat breeds. BMC Genomics 11(1):406
Munroe PB, Barnes MR, Caulfield MJ (2013) Advances in blood pressure genomics. Circ Res 112(10):1365–1379
New MI, Levine LS (1980) Hypertension of Childhood with Suppressed Renin. Endocr Rev 1(4):421–430
Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M et al (2005) Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum Mol Genet 14(13):1805–1814
Newhouse S, Farrall M, Wallace C, Hoti M, Burke B, Howard P et al (2009) Polymorphisms in the WNK1 gene are asociated with blood pressure variation and urinary potassium excretion. PLoS One 4(4):e5003
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L et al (2009a) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41(6):666–676
Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A et al (2009b) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41(3):348–353
Nguyen KH, Pihur V, Ganesh SK, Rakha A, Richard S, Hunt SC et al (2014) Effects of rare and common blood pressure gene variants on essential hypertension: results from the FBPP, CLUE ARIC studies. Circ Res 112(2):318–326
Ohta A, Schumacher F-R, Mehellou Y, Johnson C, Knebel A, Macartney TJ et al (2013) The CUL3–KLHL3 E3 ligase complex mutated in Gordon’s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J 451(1):111–122
Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27(3):282–293
Oldham PD, Pickering G, Fraser Roberts JA, Sowry GSC (1960) The nature of essential hypertension. Lancet 275(7134):1085–1093
Opocher G, Schiavi F (2010) Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab 24(6):943–956
Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D et al (2010) Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 6(10):e1001177
Padmanabhan S, Newton-Cheh C, Dominiczak AF (2012) Genetic basis of blood pressure and hypertension. Trends Genet 28(8):397–408
Padmanabhan S, Graham L, Ferreri NR, Graham D, McBride M, Dominiczak AF (2014) Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension. Hypertension 64(5):918–923
Padmanabhan S, Caulfield M, Dominiczak AF (2015) Genetic and molecular aspects of hypertension. Circ Res 116(6):937–959
Page IH (1960) The mosaic theory of hypertension. In: Bock KD, Cottier PT (eds) Essential hypertension: an international symposium Berne, June 7th–10th, 1960 Sponsored by CIBA. Springer, Berlin, pp 1–29
Patnaik A, Erlandson R, Lieberman P, Welches C, Marretta S (1990) Extra-adrenal pheochromocytoma (paraganglioma) in a cat. J Am Vet Med Assoc 197(1):104–106
Pickering G (1955) The genetic factor in essential hypertension. Ann Intern Med 43(3):457–464
Pinto YM, Paul M, Ganten D (1998) Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39(1):77–88
Polderman TJC, Benyamin B, De Leeuw CA, Sullivan PF, Van Bochoven A, Visscher PM et al (2015) Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 47(7):702–709
Pontius JU, Mullikin JC, Smith DR, Lindblad-Toh K, Gnerre S, Clamp M et al (2007) Initial sequence and comparative analysis of the cat genome. Genome Res 17:1675–1689
Russo A, Di Gaetano C, Cugliari G, Matullo G (2018) Advances in the genetics of hypertension: The effect of rare variants. Int J Mol Sci 19(3):1–21
Salvi E, Kutalik Z, Glorioso N, Benaglio P, Frau F, Kuznetsova T et al (2012) Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 59(2):248–255
Salvi E, Kuznetsova T, Thijs L, Lupoli S, Stolarz-Skrzypek K, D’Avila F et al (2013) Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension 62(5):844–852
Scholl UI, Lifton RP (2013) New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Curr Opin Nephrol Hypertens 22(2)
Scholl UI, Goh G, Stölting G, De Oliveira RC, Choi M, Overton JD et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45(9):1050–1054
Schumacher F-R, Sorrell FJ, Alessi DR, Bullock AN, Kurz T (2014) Structural and biochemical characterization of the KLHL3–WNK kinase interaction important in blood pressure regulation. Biochem J 460(2):237–246
Schuster H, Wienker TF, Bähring S, Bilginturan N, Toka HR, Neitzel H et al (1996) Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet 13(1):98–100
Scolari F, Izzi C, Ghiggeri GM (2015) Uromodulin: from monogenic to multifactorial diseases. Nephrol Dial Transplant 30(8):1250–1256
Seidel E, Scholl UI (2017) Genetic mechanisms of human hypertension and their implications for blood pressure physiology. Physiol Genomics 49(11):630–652
Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M et al (1994) Liddle’s syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79(3):407–414
Skinner JS, Manuscript A (2012) NIH Public Access 25(2):1–19
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JHM et al (2008) Shared and distinct genetic variants in Type 1 diabetes and celiac disease. N Engl J Med 359(26):2767–2777
Snieder H, Harshfield GA, Treiber FA (2003) Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension 41(6):1196–1201
Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J et al (2015) An integrated map of structural variation in 2,504 human genomes. Nature 526(7571):75–81
Surendran P, Drenos F, Young R, Warren H, Cook JP, Manning AK et al (2016) Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet 48(10):1151–1161
Syme H, Barber P, Markwell P, Elliott J (2002) Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 220(12):1799–1804
Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J et al (2005) Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 112(22):3423–3429
Tobin MD, Tomaszewski M, Braund PS, Hajat C, Raleigh SM, Palmer TM et al (2008) Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension 51(6):1658–1664
Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N et al (2014) Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am J Hum Genet 94(3):349–360
Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M et al (2013) Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 19(12):1655–1660
Unseld M, Marienfeld J, Brandt P, Brennicke A (1997) Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 15:57–61
Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD et al (2011) Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 43(10):1005–1012
Walker DJ, Elliott J, Syme HM (2009) Urinary cortisol/cortisone ratios in hypertensive and normotensive cats. J Feline Med Surg 11(6):442–448
Wang Y, O’Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ et al (2009) Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A 106(1):226–231
Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18(6):253–276
Welling PA (2014) Rare mutations in renal sodium and potassium transporter genes exhibit impaired transport function. Curr Opin Nephrol Hypertens 23(1):1–8
Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Willams C, Desitter I et al (2001) Human hypertension caused by mutations in WNK kinases. Science 293(5532):1107–1112
Zuk O, Hechter E, Sunyaev SR, Lander ES (2012) The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 109(4):1193–1198
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jepson, R.E. (2020). Genetics of Hypertension: The Human and Veterinary Perspectives. In: Elliott, J., Syme, H., Jepson, R. (eds) Hypertension in the Dog and Cat. Springer, Cham. https://doi.org/10.1007/978-3-030-33020-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-33020-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33019-4
Online ISBN: 978-3-030-33020-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)